Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Leal

Showing results (41-50 of 80) with videos related to

Pageof 8
Sort By:
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|June 27, 2014
An analysis of fosaprepitant-induced venous toxicity in patients receiving highly emetogenic chemotherapyLivia T Hegerova, Alexis D Leal, Darryl C Grendahl, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|September 13, 2013
Antiemetic prescribing practices using a computerized physician order entry systemKunal C Kadakia, Alexis D Leal, Drew K Seisler, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|March 11, 2018
Ten-Year Trends in Antiemetic Prescribing in Patients Receiving Highly Emetogenic ChemotherapyCiara C O'Sullivan, Holly K Van Houten, Lindsey R Sangaralingham, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|January 10, 2014
Fosaprepitant-induced phlebitis: a focus on patients receiving doxorubicin/cyclophosphamide therapyA D Leal, K C Kadakia, S Looker, et al.
Auto- Immunity Highlights|April 8, 2020
HERV-K and HERV-W transcriptional activity in myalgic encephalomyelitis/chronic fatigue syndromeLucas S Rodrigues, Luiz H da Silva Nali, Cibele O D Leal, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|August 5, 2025
Real-World Analysis of Irinotecan With or Without Fluorouracil in the Second-Line Treatment of Metastatic Colorectal CancerRobert W Lentz, Junxiao Hu, Hannah Robinson, et al.
Rapid Communications in Mass Spectrometry : RCM|October 26, 2010
Analysis of exemestane and 17β-hydroxyexemestane in human urine by gas chromatography/mass spectrometry: development and validation of a method using MO-TMS derivativesGustavo de A Cavalcanti, Bruno C Garrido, Felipe D Leal, et al.
Acta Histochemica|January 12, 2022
Exposure to aluminium chloride during the peripuberal period induces prostate damage in male ratsFranciely A V D Leal, Gessica D Gonçalves, João Gabriel M Soncini, et al.
Cancer Chemotherapy and Pharmacology|March 26, 2023
Correction to: A phase I, first-in-human study of TAK-164, an antibody-drug conjugate, in patients with advanced gastrointestinal cancers expressing guanylyl cyclase CRichard Kim, Alexis D Leal, Aparna Parikh, et al.
Cancer Chemotherapy and Pharmacology|February 4, 2023
A phase I, first-in-human study of TAK-164, an antibody-drug conjugate, in patients with advanced gastrointestinal cancers expressing guanylyl cyclase CRichard Kim, Alexis D Leal, Aparna Parikh, et al.
Pageof 8

Showing results (41-50 of 80) with videos related to

Sort By:
Pageof 8
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|June 27, 2014
An analysis of fosaprepitant-induced venous toxicity in patients receiving highly emetogenic chemotherapyLivia T Hegerova, Alexis D Leal, Darryl C Grendahl, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|September 13, 2013
Antiemetic prescribing practices using a computerized physician order entry systemKunal C Kadakia, Alexis D Leal, Drew K Seisler, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|March 11, 2018
Ten-Year Trends in Antiemetic Prescribing in Patients Receiving Highly Emetogenic ChemotherapyCiara C O'Sullivan, Holly K Van Houten, Lindsey R Sangaralingham, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|January 10, 2014
Fosaprepitant-induced phlebitis: a focus on patients receiving doxorubicin/cyclophosphamide therapyA D Leal, K C Kadakia, S Looker, et al.
Auto- Immunity Highlights|April 8, 2020
HERV-K and HERV-W transcriptional activity in myalgic encephalomyelitis/chronic fatigue syndromeLucas S Rodrigues, Luiz H da Silva Nali, Cibele O D Leal, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|August 5, 2025
Real-World Analysis of Irinotecan With or Without Fluorouracil in the Second-Line Treatment of Metastatic Colorectal CancerRobert W Lentz, Junxiao Hu, Hannah Robinson, et al.
Rapid Communications in Mass Spectrometry : RCM|October 26, 2010
Analysis of exemestane and 17β-hydroxyexemestane in human urine by gas chromatography/mass spectrometry: development and validation of a method using MO-TMS derivativesGustavo de A Cavalcanti, Bruno C Garrido, Felipe D Leal, et al.
Acta Histochemica|January 12, 2022
Exposure to aluminium chloride during the peripuberal period induces prostate damage in male ratsFranciely A V D Leal, Gessica D Gonçalves, João Gabriel M Soncini, et al.
Cancer Chemotherapy and Pharmacology|March 26, 2023
Correction to: A phase I, first-in-human study of TAK-164, an antibody-drug conjugate, in patients with advanced gastrointestinal cancers expressing guanylyl cyclase CRichard Kim, Alexis D Leal, Aparna Parikh, et al.
Cancer Chemotherapy and Pharmacology|February 4, 2023
A phase I, first-in-human study of TAK-164, an antibody-drug conjugate, in patients with advanced gastrointestinal cancers expressing guanylyl cyclase CRichard Kim, Alexis D Leal, Aparna Parikh, et al.
Pageof 8